S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pluristem and Hadassah Medical Center Announce Significant Data Showing PLX-R18 Cells Improve Bone Marrow Transplantation (2015/3/3)|
|Significant Findings in U.S. National Institutes of Health's Trial of Pluristem's PLX-R18 Cells for Treatment of Acute Radiation Syndrome (2015/2/18)|
|Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months (2015/2/2)|
|New Published Data Show Pluristem's PLX Cells Protect Neurons (2014/12/22)|
|Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes (2014/12/4)|
|Pluristem Issues Letter to Shareholders (2015/1/12)|
|Updated Coverage Report Focuses on Pluristem Therapeutics (2015/1/27)|
|Avago Technologies Limited Announces First Quarter Fiscal Year 2015 Financial Results (2015/2/25)|
|Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa (2015/1/6)|
|TigerLogic Announces Changes to its Board of Directors (2015/1/23)|
Click above to view more mutual fund data and stats for plx - Protalix BioTherapeutics Inc.